TC Energy Corp
TRP
Choice Properties Real Estate Investment Trust
CHP.UN
Emera Inc
EMA
Bank of Nova Scotia
BNS
Enbridge Inc
ENB
CA Stock MarketDetailed Quotes
HLS HLS Therapeutics Inc
- 3.920
- -0.070-1.75%
15min DelayMarket Closed Mar 11 15:55 ET
124.63MMarket Cap-4.20P/E (TTM)
4.070High3.920Low3.10KVolume4.070Open3.990Pre Close12.28KTurnover5.48052wk High0.02%Turnover Ratio31.79MShares3.00052wk Low-0.933EPS TTM75.44MFloat Cap24.598Historical HighLossP/E (Static)19.25MShs Float0.043Historical Low-1.127EPS LYR3.76%Amplitude--Dividend TTM1.09P/B1Lot Size--Div YieldTTM
HLS Therapeutics Inc News
HLS Therapeutics Inc Is Maintained at Hold by Canaccord Genuity
HLS Therapeutics Inc (HLTRF) Q3 2024 Earnings Call Highlights: Strategic Debt Reduction and ...
HLS Therapeutics Q2 Net Loss Narrows With Cut in Expenses, Revenue Falls
Press Release: HLS Therapeutics Announces Q2 2024 Financial Results
Strategic Divestiture and Financial Flexibility: HLS Therapeutics Inc's Optimistic Buy Rating
Stifel Nicolaus Keeps Their Hold Rating on HLS Therapeutics Inc (HLS)
Stocks in Play: HLS Therapeutics Inc.
New Study Published on the Impact of Pharmaceutical Support Programs on Persistence With Clozapine Treatment
HLS Therapeutics Meets Q1 Earnings Forecast, But Misses on Revs; Lowers 2024 Vascepa Guidance
HLS Therapeutics Inc: INTERIM MDA EN
HLS Therapeutics Inc: INTERIM FINANCIAL STATEMENTSREPORT EN
Press Release: HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call
HLS Therapeutics Inc: AUDITED ANNUAL FINANCIAL STATEMENTS AMENDED EN
HLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
HLS Therapeutics Inc Price Target Cut to C$5.00/Share From C$6.50 by Raymond James
Earnings Release: Here's Why Analysts Cut Their HLS Therapeutics Inc. (TSE:HLS) Price Target To CA$6.57
HLS Therapeutics Inc Price Target Cut to C$4.15/Share From C$4.35 by Stifel Nicolaus
HLS Therapeutics Inc. (TSE:HLS) Stock Most Popular Amongst Retail Investors Who Own 40%, While Hedge Funds Hold 39%
HLS Therapeutics Reports Q4 2023 Net Loss of US$5.4 Million; Provides 2024 Outlook, Credit Agreement Update
HLS Therapeutics Inc: MDA EN
Trending Stocks
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.